
July 2022, Vol 140, No. 7, Pages 662-748
Editorial
1. Identifying Glaucoma in Primary Care Offices
- Harry A. Quigley, MD
- JAMA Ophthalmol. 2022;140(7):663-664. doi:10.1001/jamaophthalmol.2022.1608
- PDF
2. Visual Acuity Screening in Older Adults
- Ruth D. Williams, MD
- JAMA Ophthalmol. 2022;140(7):665-666. doi:10.1001/jamaophthalmol.2022.1758
- PDF
Original Investigation
3. Nationwide Incidence of Thyroid Eye Disease and Cumulative Incidence of Strabismus and Surgical Interventions in Denmark
- Lena Boulakh, MD; Birte Nygaard, MD, PhD; Toke Bek, MD, DMSci; et al.
- JAMA Ophthalmol. 2022;140(7):667-673. doi:10.1001/jamaophthalmol.2022.1002
- PDF
4. Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study
- Joëlle E. Vergroesen, MSc; Eric F. Thee, MD; Fariba Ahmadizar, PhD; et al.
- JAMA Ophthalmol. 2022;140(7):674-681. doi:10.1001/jamaophthalmol.2022.1435
- PDF
5. Association Between Retinal Layer Thickness and Cognitive Decline in Older Adults
- Hyeong Min Kim, MD, MSc; Ji Won Han, MD, PhD; Young Joo Park, MD, MSc; et al.
- JAMA Ophthalmol. 2022;140(7):683-690. doi:10.1001/jamaophthalmol.2022.1563
- PDF
6. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration ProgressionAREDS2 Report 28
- Emily Y. Chew, MD; Traci E. Clemons, PhD; Elvira Agrón, MA; et al.
- JAMA Ophthalmol. 2022;140(7):692-698. doi:10.1001/jamaophthalmol.2022.1640
- PDF
7. Association Between Retinal Microanatomy in Preterm Infants and 9-Month Visual Acuity
- Kai R. Seely, MHSc; Shwetha Mangalesh, MD; Liangbo L. Shen, MD; et al.
- JAMA Ophthalmol. 2022;140(7):699-706. doi:10.1001/jamaophthalmol.2022.1643
- PDF
8. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US AdultsA Randomized Clinical Trial
- William G. Christen, ScD; Nancy R. Cook, ScD; JoAnn E. Manson, MD, DrPH; et al.
- JAMA Ophthalmol. 2022;140(7):707-714. doi:10.1001/jamaophthalmol.2022.1818
- PDF
9. Cost of Ranibizumab Port Delivery System vs Intravitreal Injections for Patients With Neovascular Age-Related Macular Degeneration
- Shefali Sood, MD, MPA; Jordan Mandell, BS; Arjun Watane, MD; et al.
- JAMA Ophthalmol. 2022;140(7):716-723. doi:10.1001/jamaophthalmol.2022.1819
- PDF
Brief Report
10. Integrated Visualization Highlighting Retinal Changes in Retinopathy of Prematurity From 3-Dimensional Optical Coherence Tomography Data
- Shwetha Mangalesh, MBBS; Kai R. Seely, MHSc; Du Tran-Viet, BS; et al.
- JAMA Ophthalmol. 2022;140(7):725-729. doi:10.1001/jamaophthalmol.2022.1344
- PDF
11. Early-Onset TIMP3-Related Retinopathy Associated With Impaired Signal Peptide
- Bin Guan, PhD; Laryssa A. Huryn, MD; Andrew B. Hughes, BS; et al.
- JAMA Ophthalmol. 2022;140(7):730-733. doi:10.1001/jamaophthalmol.2022.1822
- PDF
Invited Commentary
12. A Call for Health Equity in Diabetic Care to Improve Eye Health
- Emily A. Eton, MD; Paula Anne Newman-Casey, MD, MS
- JAMA Ophthalmol. 2022;140(7):681-682. doi:10.1001/jamaophthalmol.2022.1436
- PDF
13. Retinal Imaging as a Predictor of Cognitive Impairment
- Rajendra S. Apte, MD, PhD
- JAMA Ophthalmol. 2022;140(7):691. doi:10.1001/jamaophthalmol.2022.1721
- PDF
14. Another Disappointment for ω-3 Fatty Acid and Dry Eye Disease
- Penny A. Asbell, MD, MBA; Maureen G. Maguire, PhD
- JAMA Ophthalmol. 2022;140(7):714-715. doi:10.1001/jamaophthalmol.2022.1821
- PDF
15. Is There a Cost Benefit to the Ranibizumab Port Delivery System?
- Shriji Patel, MD, MBA; Paul Sternberg Jr, MD
- JAMA Ophthalmol. 2022;140(7):723-724. doi:10.1001/jamaophthalmol.2022.1820
- PDF
JAMA Ophthalmology Clinical Challenge
16. Bilateral Papilledema and Intact Vision With Normal Intracranial Pressure
- Vishal Swaminathan, BS; M. Tariq Bhatti, MD; John J. Chen, MD, PhD
- JAMA Ophthalmol. 2022;140(7):734-735. doi:10.1001/jamaophthalmol.2022.0261
- PDF
17. Sudden-Onset Monocular Blurry Vision in a Young Woman
- Ines Lains, MD, PhD; Mohammad Dahrouj, MD, PhD; Dean Eliott, MD
- JAMA Ophthalmol. 2022;140(7):736-737. doi:10.1001/jamaophthalmol.2022.1327
- PDF
18. An Unusual Case of Severe Bilateral Extraocular Muscle Enlargement
- Katherine M. Lucarelli, MD; Katherine G. Chen, MD; Sruti S. Akella, MD
- JAMA Ophthalmol. 2022;140(7):738-739. doi:10.1001/jamaophthalmol.2022.0265
- PDF
19. A Middle-aged Man With Macular Lesions and Vitritis
- Jason Fan, MD, PhD; Chris Y. Wu, MD; Janet L. Davis, MD
- JAMA Ophthalmol. 2022;140(7):740-741. doi:10.1001/jamaophthalmol.2022.0270
- PDF
20. Elevated Intraocular Pressure With Visual Deterioration in a Pseudophakic Eye
- Thomas Falb, MD; Ewald Lindner, MD, PD, MBA
- JAMA Ophthalmol. 2022;140(7):742-743. doi:10.1001/jamaophthalmol.2022.0641
- PDF
Observation
21. Cytology-Proven Primary Vitreoretinal Lymphoma in a Patient With Paraneoplastic Cloudy Vitelliform Submaculopathy
- Nicholas E. Kalafatis, MD; Kushal U. Agrawal, MS; Hormoz Ehya, MD; et al.
- JAMA Ophthalmol. 2022;140(7):744-745. doi:10.1001/jamaophthalmol.2022.1554
- PDF
Ophthalmic Images
22. Adult Female Patient with Giant Periorbital Hidrocystomas
- Rona Z. Silkiss, MD; Sarah E. Eppley, MD
- JAMA Ophthalmol. 2022;140(7):e221011. doi:10.1001/jamaophthalmol.2022.1011
- PDF
23. Congenital Lamellar and Sutural Cataract in a Patient With Type 2 Diabetes
- Rupin N. Parikh, MD; Carolyn E. Kloek, MD
- JAMA Ophthalmol. 2022;140(7):e222158. doi:10.1001/jamaophthalmol.2022.2158
- PDF
24. Pseudorheumatoid Nodules of the Eyelid in a Boy Aged 4 Years
- Samantha M. Arsenault, MD; Katherine Williams, MD; Richard C. Allen, MD, PhD
- JAMA Ophthalmol. 2022;140(7):e222162. doi:10.1001/jamaophthalmol.2022.2162
- PDF
25. Retinopathy in Presumed Congenital Rubella Syndrome
- Minsoo Kim, BS; Amir H. Kashani, MD, PhD
- JAMA Ophthalmol. 2022;140(7):e222166. doi:10.1001/jamaophthalmol.2022.2166
- PDF
Comment & Response
26. Reevaluating the Risk of Serious Adverse Events of Carbonic Anhydrase Inhibitors
- Isaac D. Bleicher, MD; Elizabeth J. Rossin, MD, PhD; Demetrios G. Vavvas, MD, PhD
- JAMA Ophthalmol. 2022;140(7):745-746. doi:10.1001/jamaophthalmol.2022.1565
- PDF
27. Reevaluating the Risk of Serious Adverse Events of Carbonic Anhydrase Inhibitors—Reply
- Marko M. Popovic, MD; Matthew B. Schlenker, MD, MSc; Donald A. Redelmeier, MD, MSHSR
- JAMA Ophthalmol. 2022;140(7):746-747. doi:10.1001/jamaophthalmol.2022.1568
- PDF
28. Associations Between the Global Cognitive Performance and the Optical Coherence Tomography Optic-Nerve Measurements
- Zhiqiang Guan, MD; Kunliang Qiu, MD, PhD; Mingzhi Zhang, MD
- JAMA Ophthalmol. 2022;140(7):747. doi:10.1001/jamaophthalmol.2022.1797
- PDF
29. Associations Between the Global Cognitive Performance and the Optical Coherence Tomography Optic-Nerve Measurements
- Muhammad Z. Chauhan, MS, MA; Abdelrahman M. Elhusseiny, MD
- JAMA Ophthalmol. 2022;140(7):747-748. doi:10.1001/jamaophthalmol.2022.1800
- PDF
30. Associations Between the Global Cognitive Performance and the Optical Coherence Tomography Optic-Nerve Measurements—Reply
- Ashleigh Barrett-Young, PhD; Richie Poulton, PhD
- JAMA Ophthalmol. 2022;140(7):748. doi:10.1001/jamaophthalmol.2022.1803
- PDF
JAMA Ophthalmology Masthead
31. JAMA Ophthalmology
- JAMA Ophthalmol. 2022;140(7):662. doi:10.1001/jamaophthalmol.2021.4253
- PDF